Eleven Hundred Crore Profit Stocks to Buy in November 2026: 5 Names on the Watchlist

The eleven hundred crore profit stocks to buy in November 2026 start with five listed names: Ajanta Pharma, Apar Industries, Fortis Healthcare, Uno Minda and Paradeep Phosphates. These five companies each reported FY26 net profit between about Rs 977 crore and Rs 1,284 crore, and they range from pharma to fertilisers.

This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these eleven hundred crore profit stocks to buy to a portfolio. All prices are NSE closing prices of 12 November 2026, and financials come from company filings.

Click Here – Get Free Investment Predictions

Which Are the Best Eleven Hundred Crore Profit Stocks to Buy in November 2026?

The best eleven hundred crore profit stocks to buy in November 2026 for a watchlist are Ajanta Pharma, Apar Industries, Fortis Healthcare, Uno Minda and Paradeep Phosphates. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.

Company	CMP (Rs)	Market Cap	P/E	ROE	Dividend Yield
Ajanta Pharma	3,324	Rs 43,234 crore	38.10	23.33%	0.81%
Apar Industries	14,358	Rs 64,515 crore	54.60	18.11%	0.37%
Fortis Healthcare	760.00	Rs 56,890 crore	53.14	10.53%	0.13%
Uno Minda	1,386	Rs 63,290 crore	49.04	17.53%	0.24%
Paradeep Phosphates	143.87	Rs 14,337 crore	13.38	14.69%	1.09%

On valuation, Fortis Healthcare and Paradeep Phosphates trade below the industry P/E; Ajanta Pharma sits close to it; Apar Industries and Uno Minda carry a premium. Valuation is the first filter for any eleven hundred crore profit stocks to buy list, and it is covered again in the risk section.

Why These Eleven Hundred Crore Profit Stocks to Buy Are in Focus

In this list, FY26 net profit and revenue both grew for every company, and quarterly profit in the latest reported quarter was higher than a year earlier for all five. The list covers a branded pharma company, a conductors and cables maker, a hospital chain, an auto components maker and a fertiliser producer. Investors comparing the best eleven hundred crore profit stocks in India usually check earnings growth, dividends and how the shares are valued.

Ajanta Pharma: The Branded Generics Specialist Among Eleven Hundred Crore Profit Stocks to Buy

Ajanta Pharma is a branded generics company with a strong presence in dermatology, ophthalmology and cardiology in India, Africa and Asia. At Rs 3,324, the stock has a market capitalisation of Rs 43,234 crore and trades at 38.10 times earnings, while the industry P/E is 37.65.

Reported numbers show FY26 revenue of Rs 5,625 crore, up 18.6% year on year, with net profit at Rs 1,056 crore, up 14.7%. The June 2026 quarter added revenue of Rs 1,697 crore (up 27.7%) and net profit of Rs 334 crore (up 30.9%).

Return on equity is 23.33%, debt-to-equity is 0.06, and the dividend yield is 0.81%. Promoters hold 63.47%, foreign institutions 7.63% and domestic institutions 21.94% as of September 2026. Domestic institutional holding has risen from 17.90% to 21.94% over the last year.

Apar Industries: The Conductor and Specialty Cable Name Among Eleven Hundred Crore Profit Stocks to Buy

Apar Industries is a maker of conductors, power transmission cables and speciality oils. Its market capitalisation is Rs 64,515 crore, the share price is Rs 14,358 and the P/E of 54.60 compares with an industry P/E of 41.42.

Over FY26, net profit rose 18.9% to Rs 977 crore on revenue of Rs 22,967 crore, which was up 22.9%. The latest quarter, the June 2026 quarter, brought revenue of Rs 6,625 crore, up 29.2% year on year, and net profit of Rs 467 crore, up 77.8%.

Return on equity is 18.11%, debt-to-equity is 0.18, and the dividend yield is 0.37%. Promoters hold 55.42%, foreign institutions 12.55% and domestic institutions 23.82% as of September 2026. Foreign institutional holding has risen from 9.35% to 12.55% over the last year.

Check Eleven Hundred Crore Profit Stocks Live on the Univest Screener

Fortis Healthcare: The Multi-City Hospital Network Among Eleven Hundred Crore Profit Stocks to Buy

Fortis Healthcare is a hospital and diagnostics network with large facilities across the country. The stock trades at Rs 760.00 with a market capitalisation of Rs 56,890 crore and a P/E of 53.14, against an industry P/E of 61.50.

FY26 revenue rose 16.9% to Rs 9,178 crore and net profit rose 31.5% to Rs 1,064 crore. In the June 2026 quarter, revenue grew 17.3% year on year to Rs 2,560 crore, while net profit grew 2.3% to Rs 273 crore.

Return on equity is 10.53%, debt-to-equity is 0.35, and the dividend yield is 0.13%. Promoters hold 31.17%, foreign institutions 23.19% and domestic institutions 34.46% as of September 2026. Domestic institutional holding has risen from 29.14% to 34.46% over the last year.

Uno Minda: The Component Supplier Among Eleven Hundred Crore Profit Stocks to Buy

Uno Minda is a component supplier with electronics and EV-related products. At Rs 1,386, the stock has a market capitalisation of Rs 63,290 crore and trades at 49.04 times earnings, while the industry P/E is 36.13.

Reported numbers show FY26 revenue of Rs 19,692 crore, up 17.2% year on year, with net profit at Rs 1,284 crore, up 25.8%. The June 2026 quarter added revenue of Rs 5,563 crore (up 23.6%) and net profit of Rs 316 crore (up 2.1%).

Return on equity is 17.53%, debt-to-equity is 0.40, and the dividend yield is 0.24%. Promoters hold 68.36%, foreign institutions 8.78% and domestic institutions 17.11% as of September 2026. Domestic institutional holding has risen from 15.80% to 17.11% over the last year.

Paradeep Phosphates: The Phosphate Fertiliser Producer Among Eleven Hundred Crore Profit Stocks to Buy

Paradeep Phosphates is a DAP and NPK fertiliser producer based in eastern India. Its market capitalisation is Rs 14,337 crore, the share price is Rs 143.87 and the P/E of 13.38 compares with an industry P/E of 20.30.

Over FY26, net profit rose 50.5% to Rs 996 crore on revenue of Rs 21,973 crore, which was up 28.4%. The latest quarter, the June 2026 quarter, brought revenue of Rs 6,146 crore, up 35.4% year on year, and net profit of Rs 393 crore, up 23.9%.

Return on equity is 14.69%, debt-to-equity is 1.02, and the dividend yield is 1.09%. Promoters hold 57.85%, foreign institutions 4.79% and domestic institutions 20.26% as of September 2026. Domestic institutional holding has risen from 12.99% to 20.26% over the last year. A point to keep in view: debt is higher than most names on this list.

Download the Univest iOS App or Univest Android App to track these eleven hundred crore profit stocks live and get daily stock recommendations.

Growth Snapshot: Latest Full Year and Latest Quarter

The table compares year-on-year growth in revenue and net profit for all five eleven hundred crore profit stocks, using filed results.

Company	Full-Year Revenue Growth	Full-Year Profit Growth	Latest Quarter	Quarter Revenue Growth	Quarter Profit Growth
Ajanta Pharma	18.6%	14.7%	Jun 2026	27.7%	30.9%
Apar Industries	22.9%	18.9%	Jun 2026	29.2%	77.8%
Fortis Healthcare	16.9%	31.5%	Jun 2026	17.3%	2.3%
Uno Minda	17.2%	25.8%	Jun 2026	23.6%	2.1%
Paradeep Phosphates	28.4%	50.5%	Jun 2026	35.4%	23.9%

Factors That Move Eleven Hundred Crore Profit Stocks to Buy

Four factors tend to drive eleven hundred crore profit stocks, and each one is worth checking before a purchase.

• Scale: Each earned above Rs 950 crore in FY26.
• Dividends: Paradeep Phosphates yields about 1.1%.
• Return on equity: Ajanta Pharma leads at about 23%.
• Valuation: P/E runs from about 13 to 55.

Risks to Keep in Mind Before Buying Eleven Hundred Crore Profit Stocks

The first risk is that Apar Industries trades at a P/E near 55, Fortis Healthcare near 53 and Uno Minda near 49, while Paradeep Phosphates trades near 13, so expectations differ widely. The second is that Paradeep Phosphates carries the highest borrowings of the five and fertiliser earnings follow subsidy timing. Check results every quarter.

On the numbers, Apar Industries trades at the highest P/E on this list at 54.60, so its earnings need to keep growing to support the price. Eleven Hundred Crore Profit stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.

How to Choose Eleven Hundred Crore Profit Stocks to Buy

• Compare growth: Paradeep Phosphates grew FY26 profit most, by about 51%.
• Check P/E: Paradeep Phosphates trades lowest.
• Read the yield: Paradeep Phosphates pays the most.
• Spread sectors: Mix pharma, cables, hospitals, auto parts and fertilisers.

How to Invest in Eleven Hundred Crore Profit Stocks

1. Shortlist two or three companies from this list that match your risk appetite.
2. Open the Univest Screener and compare P/E, ROE and debt for each stock.
3. Check the latest quarterly results and shareholding pattern on NSE or BSE.
4. Decide an amount you can hold for three to five years and split it into two or three purchases.
5. Review the holding after every quarterly result instead of reacting to daily price moves.

Conclusion

Paradeep Phosphates offers the lowest P/E on this list at 13.38, Ajanta Pharma has the highest return on equity at 23.33%, and Paradeep Phosphates posted the fastest net profit growth in its latest full year at 50.5%. Among the best eleven hundred crore profit stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these eleven hundred crore profit stocks to buy.

Frequently Asked Questions on Eleven Hundred Crore Profit Stocks to Buy

Which are the best eleven hundred crore profit stocks to buy in November 2026?

Ans. The five eleven hundred crore profit stocks on the November 2026 watchlist are Ajanta Pharma, Apar Industries, Fortis Healthcare, Uno Minda and Paradeep Phosphates. Paradeep Phosphates has the lowest P/E at 13.38, Ajanta Pharma has the highest ROE at 23.33%, and Paradeep Phosphates grew net profit 50.5% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.

Is Apar Industries a good stock to buy from this Eleven Hundred Crore Profit list?

Ans. Apar Industries is the largest company on this list with a market capitalisation of Rs 64,515 crore and a P/E of 54.60 against an industry P/E of 41.42. Its FY26 revenue rose 22.9% and net profit rose 18.9%, with return on equity at 18.11%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.

Are these eleven hundred crore profit stocks expensive right now?

Ans. Valuations vary across the group. Ajanta Pharma trades at a P/E of 38.10, Apar Industries trades at a P/E of 54.60, Fortis Healthcare trades at a P/E of 53.14, Uno Minda trades at a P/E of 49.04, Paradeep Phosphates trades at a P/E of 13.38, against industry multiples ranging from 20.30 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.

Which of these eleven hundred crore profit stocks pay a dividend?

Ans. Dividend yields on this list are Ajanta Pharma 0.81%, Apar Industries 0.37%, Fortis Healthcare 0.13%, Uno Minda 0.24%, Paradeep Phosphates 1.09%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.

Which stock on this list has the highest return on equity?

Ans. Ajanta Pharma has the highest ROE on this list at 23.33%, followed by Apar Industries at 18.11% and Uno Minda at 17.53%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.

What are the risks of investing in eleven hundred crore profit stocks?

Ans. The main risks are high valuations at three names, borrowings at the fertiliser producer and subsidy timing. On this list, Apar Industries trades at the highest P/E of 54.60, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.

How can I invest in eleven hundred crore profit stocks in India?

Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.